Concepedia

Herbert T. Cohen

HT

Statistics

Publications

30

Citations

2.6K

H-Index

24

Active since

1991

Affiliations

Boston University(Current)

Boston Medical Center

Harvard University

Beth Israel Deaconess Medical Center

University of Chicago

Herbert T. Cohen is an author at Boston University specializing in medicine, molecular biology, and life sciences.

ORCID

Publications per year

1991–2021

30

Publications

30

The von Hippel-Lindau Tumor Suppressor Gene Product Interacts with Sp1 To Repress Vascular Endothelial Growth Factor Promoter Activity

Debabrata Mukhopadhyay, Bertrand Knebelmann, Herbert T. Cohen et al. · Molecular and Cellular Biology · 1997 · 342 citations · Full text

, , +17

Previously unidentified changes in renal cell carcinoma gene expression identified by parametric analysis of microarray data

Marc E. Lenburg, Louis S. Liou, Norman P. Gerry et al. · BMC Cancer · 2003 · 279 citations · Full text

, , +17

Jade-1 inhibits Wnt signalling by ubiquitylating β-catenin and mediates Wnt pathway inhibition by pVHL

Vipul C. Chitalia, Rebecca L. Foy, Markus Bachschmid et al. · Nature Cell Biology · 2008 · 180 citations · Full text

, , +8

Transforming growth factor alpha is a target for the von Hippel-Lindau tumor suppressor.

Bertrand Knebelmann, Subbian Ananth, Herbert T. Cohen et al. · PubMed · 1998 · 170 citations

, , +17

Activation of Sp1-mediated Vascular Permeability Factor/Vascular Endothelial Growth Factor Transcription Requires Specific Interaction with Protein Kinase C ζ

Soumitro Pal, Kevin P. Claffey, Herbert T. Cohen et al. · Journal of Biological Chemistry · 1998 · 164 citations · Full text

, , +17

1–5 of 30